Related Experiment Video
Updated: Jul 20, 2025

05:17
Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-1451
Published on: April 18, 2025
255
Classification of Alzheimer's Progression Using fMRI Data
Ju-Hyeon Noh1, Jun-Hyeok Kim1, Hee-Deok Yang1
1Department of Computer Engineering, University of Chosun, Gwangju 61452, Republic of Korea.
Sensors (Basel, Switzerland)
|July 29, 2023
Summary
This study introduces a deep learning model using 4D functional magnetic resonance imaging (fMRI) to accurately diagnose Alzheimer's disease progression. The novel 3D-CNN-LSTM approach achieves 96.4% accuracy, offering a promising tool for early detection.
Area of Science:
- Neuroimaging
- Artificial Intelligence
- Medical Diagnostics
Background:
- Functional magnetic resonance imaging (fMRI) has advanced brain research over three decades.
- Deep learning models show promise in various complex data analysis tasks.
Purpose of the Study:
- To develop and evaluate a deep learning model for diagnosing Alzheimer's disease (AD) progression.
- To classify individuals into categories: condition normal (CN), early mild cognitive impairment (EMCI), late mild cognitive impairment (LMCI), and AD.
Main Methods:
- A 4D fMRI dataset was pre-processed in four steps to remove noise.
- A 3D-CNN-LSTM classification model was employed, utilizing U-Net for spatial feature extraction and LSTM for temporal feature extraction.
- Comparative experiments involved training three models with adjusted time dimensions.
Main Results:
- The proposed 3D-CNN-LSTM model achieved an average accuracy of 96.4% using five-fold cross-validation.
- The model effectively extracted both spatial and temporal features from fMRI data.
- The method demonstrated high potential in identifying Alzheimer's disease progression.
Conclusions:
- The developed 3D-CNN-LSTM model shows significant potential for the early identification and diagnosis of Alzheimer's disease progression using 4D fMRI data.
- This approach offers a non-invasive method for monitoring cognitive decline and disease staging.

